Beijing Airdoc Technology Co (2251.HK) Stock Price

Beijing Airdoc Technology Co Price

HKEX·CLOSED
7.49
​
Market closed

Revenue has compounded at 33.6% per year over the past 6 years to 202.04 M CNY. Beijing Airdoc Technology Co's net margin stands at -14.4%, up from -123.8% several years earlier. Analysts set a median price target of 11.28 CNY, implying 50.7% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.

Beijing Airdoc Technology Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Airdoc Technology Co business model & stock analysis

Beijing Airdoc Technology Co Ltd provides AI-powered retina-based solutions for early disease detection and health risk assessment. Its main product, Airdoc-AIFUNDUS 1.0, diagnoses conditions like glaucoma, cataract, ICVD, ASCVD, diabetic retinopathy of pregnancy, and hypertensive retinopathy of pregnancy. The company serves hospitals, community clinics, health checkup centers, insurance companies, optometry centers, and pharmacies with its Software-as-a-medical device (SaMD) solutions. These products are sold as standalone software tools for medical diagnostics and health monitoring. Airdoc-AIFUNDUS 1.0 is the core offering, targeting healthcare providers and institutions seeking AI-driven diagnostic tools. The firm's deep pipeline of SaMDs and health risk assessment solutions caters to diverse healthcare needs across the population. Customers include hospitals, community clinics, health checkup centers, insurance companies, optometry centers, and pharmacies, all leveraging the technology for improved patient outcomes and risk management. The company generates revenue through the sale of its AI-based medical device solutions to healthcare facilities and insurance providers. Hospitals and clinics use Airdoc-AIFUNDUS 1.0 for diagnostic purposes, while insurance companies integrate the technology for health risk assessment. Optometry centers and pharmacies also adopt the solutions for preventive care and patient screening.

Frequently asked questions about Beijing Airdoc Technology Co

Analysts currently set an average price target of 11.28 CNY for the Beijing Airdoc Technology Co stock (median: 11.28 CNY), implying +50.7 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Beijing Airdoc Technology Co stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Beijing Airdoc Technology Co to generate revenue of 295.91 M CNY and earnings per share of -0.43 CNY.

Converted at the current exchange rate, the Beijing Airdoc Technology Co share trades at 1.02 EUR (7.49 CNY).

The Beijing Airdoc Technology Co share (2251.HK) is listed on 1 stock exchanges, including: Hongkong (HKEX) (2251.HK).

The expected revenue of Beijing Airdoc Technology Co is 295.91 M CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Beijing Airdoc Technology Co is -44.60 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Beijing Airdoc Technology Co is currently -17.28. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Beijing Airdoc Technology Co stock.

The price-to-sales ratio (P/S) of Beijing Airdoc Technology Co is currently 2.61. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Beijing Airdoc Technology Co stock.

The Eulerpool Quality Score for Beijing Airdoc Technology Co is 3/10.

The ISIN of Beijing Airdoc Technology Co is CNE100004QQ9. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Beijing Airdoc Technology Co is 2251.HK. The ticker symbol is used to trade Beijing Airdoc Technology Co shares on the stock exchange.

Fair ValueTerminal
6.29 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
547,535.50 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website airdoc.com
Country
Currency
CNY
Initial public offering
Nov 5, 2021
ISIN
CNE100004QQ9
Cusip
Y077DR107
Market capitalization
767.41 M CNYSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-17.28
P/Ee 2027
8.73
P/S
P/Se
2.61
EV/EBIT
—
P/B Ratio
0.54
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.99 %
Last updated Nov 19, 2026, 3:45 AM

Beijing Airdoc Technology Co Peer Group

Beijing Airdoc Technology Co Ticker

HKEX · 2251.HK

Beijing Airdoc Technology Co FIGI

2251:HK · BBG012NZJ0D6